205 related articles for article (PubMed ID: 28717844)
1. Application of the Biopsy-Sparing ESPGHAN Guidelines for Celiac Disease Diagnosis in Adults: A Real-Life Study.
Efthymakis K; Serio M; Milano A; Laterza F; Bonitatibus A; Di Nicola M; Neri M
Dig Dis Sci; 2017 Sep; 62(9):2433-2439. PubMed ID: 28717844
[TBL] [Abstract][Full Text] [Related]
2. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients?
Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F
Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.
Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD
Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767
[TBL] [Abstract][Full Text] [Related]
4. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study.
Ciacci C; Bai JC; Holmes G; Al-Toma A; Biagi F; Carroccio A; Ciccocioppo R; Di Sabatino A; Gingold-Belfer R; Jinga M; Makharia G; Niveloni S; Norman GL; Rostami K; Sanders DS; Smecuol E; Villanacci V; Vivas S; Zingone F;
Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):1005-1014. PubMed ID: 37696284
[TBL] [Abstract][Full Text] [Related]
5. The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult coeliac disease without duodenal biopsy.
Tortora R; Imperatore N; Capone P; De Palma GD; De Stefano G; Gerbino N; Caporaso N; Rispo A
Aliment Pharmacol Ther; 2014 Nov; 40(10):1223-9. PubMed ID: 25263177
[TBL] [Abstract][Full Text] [Related]
6. ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19.
Trovato CM; Montuori M; Cucchiara S; Oliva S
Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1523-1526. PubMed ID: 32956181
[TBL] [Abstract][Full Text] [Related]
7. Evidence Supporting Serology-based Pathway for Diagnosing Celiac Disease in Asymptomatic Children From High-risk Groups.
Paul SP; Sandhu BK; Spray CH; Basude D; Ramani P
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):641-644. PubMed ID: 28957985
[TBL] [Abstract][Full Text] [Related]
8. Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study.
Di Tola M; Marino M; Goetze S; Casale R; Di Nardi S; Borghini R; Donato G; Tiberti A; Picarelli A
J Gastroenterol; 2016 Nov; 51(11):1031-1039. PubMed ID: 26928588
[TBL] [Abstract][Full Text] [Related]
9. Barriers to implementing the revised ESPGHAN guidelines for coeliac disease in children: a cross-sectional survey of coeliac screen reporting in laboratories in England.
Paul SP; Harries SL; Basude D
Arch Dis Child; 2017 Oct; 102(10):942-946. PubMed ID: 28483757
[TBL] [Abstract][Full Text] [Related]
10. Characterization and Short-Term Outcome of Potential Celiac Disease in Children.
Kori M; Topf-Olivestone C; Rinawi F; Lev-Tzion R; Ziv-Sokolovskaya N; Lapidot Alon N; Guz-Mark A; Shamir R
Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37511994
[No Abstract] [Full Text] [Related]
11. Prospective Evaluation of the ESPGHAN Guidelines for Diagnosis of Celiac Disease in New Zealand Children.
Bishop J; Reed P; Austin P; Hurst M; Ameratunga R; Craigie A; McFarlane J; Chin SE; Mouat SM; Evans HM
J Pediatr Gastroenterol Nutr; 2018 Dec; 67(6):749-754. PubMed ID: 29916948
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of celiac disease and applicability of ESPGHAN guidelines in Mediterranean countries: a real life prospective study.
Smarrazzo A; Misak Z; Costa S; Mičetić-Turk D; Abu-Zekry M; Kansu A; Abkari A; Bouziane-Nedjadi K; Ben Hariz M; Roma E; Velmishi V; Legarda Tamara M; Attard T; Djurisic V; Greco L; Magazzù G
BMC Gastroenterol; 2017 Jan; 17(1):17. PubMed ID: 28109250
[TBL] [Abstract][Full Text] [Related]
13. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease.
Singh P; Kurray L; Agnihotri A; Das P; Verma AK; Sreenivas V; Dattagupta S; Makharia GK
J Clin Gastroenterol; 2015 Mar; 49(3):212-7. PubMed ID: 24583754
[TBL] [Abstract][Full Text] [Related]
14. Celiac Disease Diagnosis Without Biopsy: Is a 10× ULN Antitransglutaminase Result Suitable for a Chemiluminescence Method?
Previtali G; Licini L; D'Antiga L; Marseglia A; Ravasio R; Nembrini F; Greco S; Sonzogni A; Azzarà G; Ravelli P; Alessio MG
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):645-650. PubMed ID: 28991835
[TBL] [Abstract][Full Text] [Related]
15. Prudence is necessary in the application of the new ESPGHAN criteria for celiac disease omitting duodenal biopsy: a case report.
Schirru E; Jores RD; Congia M
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):679-80. PubMed ID: 24694761
[TBL] [Abstract][Full Text] [Related]
16. [Association between anti-tissue transglutaminase antibody titers and duodenal histopathology among adults with celiac disease].
Wang M; Lu JJ; Li T; Ma CT; Li ZQ; Abudurexiti A; Hui WJ; Wang C; Sun ZZ; Gao F
Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):188-192. PubMed ID: 36746530
[TBL] [Abstract][Full Text] [Related]
17. Combining antibody tests and taking into account antibody levels improves serologic diagnosis of celiac disease.
Oyaert M; Vermeersch P; De Hertogh G; Hiele M; Vandeputte N; Hoffman I; Bossuyt X
Clin Chem Lab Med; 2015 Sep; 53(10):1537-46. PubMed ID: 25719330
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
19. Validation of no-biopsy pathway for the diagnosis of celiac disease in Asian adults: a multicenter retrospective study.
Pachisia AV; Kumari A; Mehta S; Ahmed A; Chauhan A; Agarwal A; Dwarkanathan V; Rajpoot S; Prasad S; Kumar S; Sinha SK; Sharma D; Rajput M; Das P; Falodia S; Kochhar R; Ramakrishna BS; Ahuja V; Makharia G
J Gastroenterol Hepatol; 2024 Mar; 39(3):489-495. PubMed ID: 38095156
[TBL] [Abstract][Full Text] [Related]
20. Applicability of the New ESPGHAN Guidelines for Diagnosing Coeliac Disease in Children from Resource Limited Countries.
Paul SP; Mazhar H; Spray CH
J Coll Physicians Surg Pak; 2015 Jun; 25(6):455-7. PubMed ID: 26101002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
